What is NeoGenomics's investing cash flow?

NeoGenomics (NEO) reported investing cash flow of -$5M in Q1 2026.

How has NeoGenomics's investing cash flow changed year-over-year?

NeoGenomics's investing cash flow decreased by 240.4% year-over-year, from $3.56M to -$5M.

What is the long-term trend for NeoGenomics's investing cash flow?

Over 2 years (2021 to 2025), NeoGenomics's investing cash flow has grown at a -86.0% compound annual growth rate (CAGR), from -$632.37M to -$12.34M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

NeoGenomics NEO Investing Cash Flow

Investing Cash Flow at other companies

Labcorp HoldingsLH

-$322.1M+4.1%

Quest DiagnosticsDGX

-$152M-32.2%

Personalis, Inc.PSNL

-$46.01M-104%

Guardant HealthGH

$699.42M+131%

Natera, Inc.NTRA

-$32.14M-91.1%

Tempus AI, Inc.TEM

-$10.07M+97.3%

Other financials

Income statement

See full

Revenue$186.7M+11.1%

Gross profit$80.9M+10.4%

Operating income-$18.2M+34.4%

Net income-$17.1M+34.0%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$146.1M-57.8%

Total debt$66.3M+5.3%

Total equity$828.8M-6.7%

Total assets$1.3B-15.9%

Cash flow

See full

Operating cash flow-$8.1M+67.9%

CapEx$5.0M+11.1%

Free cash flow-$13.1M+56.0%

Valuation

See full

Market cap$1.68B-21.0%

Enterprise value$1.6B-5.6%

P/S2.3×-0.9×

Profitability

See full

Gross margin43.2%-1.1pp

Operating margin-14.2%+1.1pp

Net margin-13.3%+2.4pp

FCF margin-4.9%—

Returns & leverage

See full

Return on equity-11.6%+6.2pp

Debt / equity0.1×0.0×

Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NeoGenomics's investing cash flow?: NeoGenomics (NEO) reported investing cash flow of -$5M in Q1 2026.
How has NeoGenomics's investing cash flow changed year-over-year?: NeoGenomics's investing cash flow decreased by 240.4% year-over-year, from $3.56M to -$5M.
What is the long-term trend for NeoGenomics's investing cash flow?: Over 2 years (2021 to 2025), NeoGenomics's investing cash flow has grown at a -86.0% compound annual growth rate (CAGR), from -$632.37M to -$12.34M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.